{"id":"https://openalex.org/W2080943178","doi":"https://doi.org/10.1111/j.1476-5381.1982.tb09232.x","title":"A STUDY OF THE INHIBITORY EFFECTS OF SCH 28080 ON GASTRIC SECRETION IN MAN","display_name":"A STUDY OF THE INHIBITORY EFFECTS OF SCH 28080 ON GASTRIC SECRETION IN MAN","alternate_titles":[],"publication_year":1982,"publication_date":"1982-07-01","ids":{"openalex":"https://openalex.org/W2080943178","doi":"https://doi.org/10.1111/j.1476-5381.1982.tb09232.x","mag":"2080943178","pmid":"https://pubmed.ncbi.nlm.nih.gov/7104515","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2071808"},"language":"en","primary_location":{"id":"doi:10.1111/j.1476-5381.1982.tb09232.x","doi":"https://doi.org/10.1111/j.1476-5381.1982.tb09232.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.1982.tb09232.x","pdf_url":null,"source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2080943178"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2071808","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039604455","display_name":"M D Ene","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802901496","display_name":"Bristol Royal Infirmary","ror":"https://ror.org/031p4kj21","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802901496","https://openalex.org/I4405276282"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M.D. ENE","raw_affiliation_strings":["Clinical Pharmacology Unit, University Department of Medicine, Bristol Royal Infirmary, Bristol BS2 8HW"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology Unit, University Department of Medicine, Bristol Royal Infirmary, Bristol BS2 8HW","institution_ids":["https://openalex.org/I2802901496"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5098328086","display_name":"T. KHAN\u2010DANESHMEND","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802901496","display_name":"Bristol Royal Infirmary","ror":"https://ror.org/031p4kj21","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802901496","https://openalex.org/I4405276282"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"T. KHAN\u2010DANESHMEND","raw_affiliation_strings":["Clinical Pharmacology Unit, University Department of Medicine, Bristol Royal Infirmary, Bristol BS2 8HW"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology Unit, University Department of Medicine, Bristol Royal Infirmary, Bristol BS2 8HW","institution_ids":["https://openalex.org/I2802901496"]}]},{"author_position":"last","author":{"id":null,"display_name":"C.J.C. ROBERTS","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802901496","display_name":"Bristol Royal Infirmary","ror":"https://ror.org/031p4kj21","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802901496","https://openalex.org/I4405276282"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C.J.C. ROBERTS","raw_affiliation_strings":["Clinical Pharmacology Unit, University Department of Medicine, Bristol Royal Infirmary, Bristol BS2 8HW"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology Unit, University Department of Medicine, Bristol Royal Infirmary, Bristol BS2 8HW","institution_ids":["https://openalex.org/I2802901496"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I2802901496"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":1.2238,"has_fulltext":false,"cited_by_count":44,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.77121237,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"76","issue":"3","first_page":"389","last_page":"391"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10671","display_name":"Gastroesophageal reflux and treatments","score":0.21199999749660492,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10671","display_name":"Gastroesophageal reflux and treatments","score":0.21199999749660492,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10276","display_name":"Helicobacter pylori-related gastroenterology studies","score":0.1835000067949295,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.12290000170469284,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sch-28080","display_name":"SCH 28080","score":0.9990000128746033},{"id":"https://openalex.org/keywords/gastric-acid-secretion","display_name":"gastric acid secretion","score":0.8989999890327454},{"id":"https://openalex.org/keywords/antisecretory-activity","display_name":"antisecretory activity","score":0.7680000066757202},{"id":"https://openalex.org/keywords/peptic-activity","display_name":"peptic activity","score":0.8569999933242798},{"id":"https://openalex.org/keywords/pentagastrin-stimulation","display_name":"pentagastrin stimulation","score":0.9670000076293945},{"id":"https://openalex.org/keywords/anti-ulcer-agents","display_name":"anti-ulcer agents","score":0.8059999942779541},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.3869999945163727}],"concepts":[{"id":"https://openalex.org/C2779377912","wikidata":"https://www.wikidata.org/wiki/Q423586","display_name":"Pentagastrin","level":4,"score":0.9174950122833252},{"id":"https://openalex.org/C2777504413","wikidata":"https://www.wikidata.org/wiki/Q846270","display_name":"Gastric acid","level":3,"score":0.7841235995292664},{"id":"https://openalex.org/C24998067","wikidata":"https://www.wikidata.org/wiki/Q4114622","display_name":"Stimulation","level":2,"score":0.6244382262229919},{"id":"https://openalex.org/C49039625","wikidata":"https://www.wikidata.org/wiki/Q84230","display_name":"Secretion","level":2,"score":0.6194519400596619},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5888524055480957},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5876900553703308},{"id":"https://openalex.org/C17077164","wikidata":"https://www.wikidata.org/wiki/Q1185869","display_name":"Inhibitory postsynaptic potential","level":2,"score":0.5083174109458923},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.49097970128059387},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.47475841641426086},{"id":"https://openalex.org/C2780656511","wikidata":"https://www.wikidata.org/wiki/Q172941","display_name":"Peptic ulcer","level":2,"score":0.47358494997024536},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.462080717086792},{"id":"https://openalex.org/C3019718079","wikidata":"https://www.wikidata.org/wiki/Q1029907","display_name":"Gastric secretion","level":3,"score":0.45913392305374146},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4180835783481598},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.34981226921081543},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000897","descriptor_name":"Anti-Ulcer Agents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D005744","descriptor_name":"Gastric Acid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010418","descriptor_name":"Pentagastrin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1111/j.1476-5381.1982.tb09232.x","doi":"https://doi.org/10.1111/j.1476-5381.1982.tb09232.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.1982.tb09232.x","pdf_url":null,"source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:775213","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2071808","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:2071808","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2071808/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Pharmacol","raw_type":"Text"},{"id":"pmid:7104515","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7104515","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of pharmacology","raw_type":"Journal Article"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:775213","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2071808","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":7,"referenced_works":["https://openalex.org/W1424489583","https://openalex.org/W1989334851","https://openalex.org/W2077319005","https://openalex.org/W2088702733","https://openalex.org/W2441820808","https://openalex.org/W2460391640","https://openalex.org/W2746412264"],"related_works":["https://openalex.org/W2302752766","https://openalex.org/W1585519562","https://openalex.org/W1596185709","https://openalex.org/W2093686235","https://openalex.org/W2086568504","https://openalex.org/W2411677556","https://openalex.org/W2403579063","https://openalex.org/W2018045657","https://openalex.org/W2032240275","https://openalex.org/W3102816209"],"abstract_inverted_index":{"1":[0],"SCH":[1,88],"28080":[2,89],"(2-methyl-8-(phenyl":[3],"methoxy)":[4],"imidazo-(1-2-a)":[5],"pyrine-3-acetonitrile)":[6],"is":[7,90],"a":[8],"novel":[9],"drug":[10,26,95],"unrelated":[11],"to":[12],"existing":[13],"anti-ulcer":[14,103],"agents.":[15],"2":[16],"The":[17],"effect":[18],"of":[19,24,51,74,87],"placebo":[20],"and":[21,31,44,55,68],"increasing":[22],"doses":[23],"the":[25,41,60,66,80],"on":[27],"gastric":[28,52],"acid":[29,53,75],"output":[30,76],"peptic":[32,56],"activity":[33,57,86],"was":[34,77],"examined":[35],"in":[36,40,64,92,102],"four":[37],"healthy":[38],"men,":[39],"resting":[42],"state":[43],"following":[45],"pentagastrin":[46],"stimulation.":[47],"3":[48],"Significant":[49],"inhibition":[50,73],"secretion":[54],"occurred":[58],"with":[59,79],"50":[61],"mg":[62,82],"dose":[63],"both":[65],"stimulated":[67],"unstimulated":[69],"states.":[70],"Approximately":[71],"90%":[72],"achieved":[78],"200":[81],"dose.":[83],"4":[84],"Antisecretory":[85],"confirmed":[91],"man.":[93],"This":[94],"or":[96],"an":[97],"analogue":[98],"may":[99],"have":[100],"potential":[101],"therapy.":[104]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2080943178","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
